Featured News
CARDIOLOGY NEWS
AMPEL develops a blood test for cardiovascular disease
Armie Grammer, AMPEL’s co-founder, president, and chief scientific officer of AMPEL BioSolutions, explains the company’s CardioGENE blood test for cardiovascular disease risk.
New Blood Test Can Predict Heart Disease and Guide Prophylactic Treatment
AMPEL BioSolutions’ new CardioGENE blood test predicts heart disease by identifying genetic markers and inflammatory pathways, enabling personalized, preventive therapies.
Precision Medicine Blood Test Predicts Heart Disease Before It Occurs
A precision medicine blood test can predict heart disease before it happens and provide decision support for prophylactic therapies.
AMPEL BioSolutions: Precision Medicine Blood Testing Predicts Heart Disease and Therapeutic Intervention
AMPEL BioSolutions announced a precision medicine blood test that could save lives by predicting heart disease before it happens and providing decision support for prophylactic therapies.
Charlottesville company creates early genetic test to predict heart disease
It’s a breakthrough discovery for the first-time identifying risk factors in inflammation and the immune system that lead to cardiovascular events. Outside the traditional risk factors of smoking, high fat diet and sedentary lifestyle. Cardio Gene could be a game changer
New Test Helps Predict Heart Disease in Lupus Patients
AMPEL BioSolutions has announced that its genetic precision medicine test for lupus patients could predict heart disease and provide decision support for prophylactic therapies.
New blood test could prevent premature death from heart attacks and stroke
You won’t find test tubes or chemicals at Ampel Biosolutions. Instead, the company uses computers to study huge amounts of medical information – to identify genes responsible for auto-immune, kidney, skin, neurologic and infectious diseases. Now, the firm says it’s got a blood test for cardiovascular events at an early age.
AMPEL unveils new genetic test for cardiovascular disease in lupus patients
The CardioGENE lab test identifies inherited genetic markers in blood samples which drive pathways to prevent cardiovascular issues with prophylactic targeted treatment
Heart Disease Blood Test
Ampel Bio-Solutions is working on a blood test that can find out if a person carries traits that may put them at higher risk of developing heart disease.
Lupus, coronary artery disease share genetic risk factors; data may lead to early testing
Researchers have identified shared genetic risk factors for systemic lupus erythematosus and coronary artery disease, according to data published in Cell Reports Medicine.
New Blood Test to Help Physicians Prevent Major Cardiovascular Events in Women with Lupus
Now, a genetic precision medicine test for lupus patients could save lives by predicting heart disease before it happens and providing decision support for prophylactic therapies.
Early Genetic Testing Predict Heart Disease, Novel Therapies for Women with Lupus
CLICK TO VIEW ORIGINAL ARTICLE > AMPEL BioSolutions announced a genetic precision medicine test for lupus patients that could save lives by predicting heart disease before it happens and providing decision support for prophylactic therapies. Shared genes that...










